KLF11 mediates a critical mechanism in TGF-β signaling that is inactivated by ERK-MAPK in pancreatic cancer cells

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 607-620

  Ellenrieder, Volker ^a   Buck, Anita ^a   Harth, Ana ^a   Jungert, Kerstin ^a   Buchholz, Malte ^a   Adler, Guido ^a   Urrutia, Raul ^b   Gress, Thomas M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

glutathione S transferase; GST; MAPK; mitogen activated protein kinase; PCR; polymerase chain reaction; SBE; SID; Sin3a HDAC interacting domain; Smad binding element; TGF; transforming growth factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; SMAD2 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KLF11; TRANSCRIPTION FACTOR SIN3A; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MUTANT; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 4143069155     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.05.018     Document Type: Article

References (46)

1. Massague J., Blain S.W., Lo R.S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309
2. Blobe G.C., Schiemann W.P., Lodish H.F. Role of TGFβ in human disease. N Engl J Med. 342:2000;1350-1358
3. Akhurst R.J., Derynck R. TGFβ signaling in cancer - a double-edged sword. Trends Cell Biol. 11:2001;44-51
4. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGFβ family signalling. Nature. 425:2003;577-584
5. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471
6. Massague J., Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:2000;1745-1754
7. Zhang Y., Derynck R. Regulation of Smad signaling by protein associations and signaling crosstalk. Trends Cell Biol. 9:1999;274-279
8. Wrana J.L. Crossing Smads. Sci STKE. 23:2000;RE1
9. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone M.A., Wrana J.L., Falb D. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signalling. Cell. 89:1997;1165-1173
10. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., ten Dijke P. Identification of Smad7, a TGFβ-inducible antagonist of TGF-beta signalling. Nature. 389:1997;631-635
11. de Caestecker M.P., Piek E., Roberts A.B. The role of TGFβ signaling in cancer. J Natl Cancer Inst. 92:2000;1388-1402
12. Dumont N., Arteaga C.L. Targeting the TGFβ signaling network in human neoplasia. Cancer Cell. 3:2003;531-536
13. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 12:2001;27-36
14. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Arteaga C.L. Phosphatidylinositol 3-kinase function is required for TGFβ mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 275:2000;36803-36810
15. Yu L.Y., Zhang Y.E. TGFβ-recptor activated p38 MAP kinase mediates Smad-independent TGFβ responses. EMBO J. 21:2002;3749-3759
16. Cui W., Fowlis D., Bryson S., Duffie E., Ireland H., Balmain A., Akhurst R.J. TGFβ1 inhibits the formation of benign skin tumours but enhances progression to invasive spindle cell carcinomas in transgenic mice. Cell. 86:1996;531-542
17. Ellenrieder V., Hendler S.F., Boeck W. TGFβ1 treatment leads to an epithelial-mesenchymal-transdifferentiation of pancreatic cancer cells requiring ERK2 activation. Cancer Res. 61:2001;4222-4228
18. Kang Y., Chen C.R., Massague J. A self-enabling TGFbeta response coupled to stress signalling Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell. 11:2003;915-926
19. Zaidi S.K., Sullivan A.J., van Wijnen A.J., Stein J.L., Stein G.S. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci U S A. 99:2002;8048-8053
20. Cook T., Gebelein B., Mesa K., Mladek A., Urrutia R. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J Biol Chem. 273:1998;25929-25936
21. Fernandez-Zapico M., Mladek A., Ellenrieder V., Folch-Puy E., Miller L., Urrutia R. A mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation. EMBO J. 22:2003;4748-4758
22. Cook T., Gebelein B., Belal M., Mesa K., Urrutia R. Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins. J Biol Chem. 274:1999;29500-29504
23. Asano H., Li X.S., Stamatoyannopoulos G. FKLF, a novel Kruppel-like factor that activates human embryonic and fetal beta-like globin genes. Mol Cell Biol. 19:1999;3571-3579
24. Zhang J.S., Moncrieffe M., Kaczynski J., Ellenrieder V., Prendergast F., Urrutia R. A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3a. Mol Cell Biol. 21:2001;5041-5049
25. Cook T., Urrutia R. TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth. Am J Physiol. 278:2000;G513-G521
26. Brodin G., Ahgren A., ten Dijke P., Heldin C.H., Heuchel R. Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem. 275:2000;29023-29030
27. Koinuma D., Shinozaki M., Komuro A., Goto K., Saitoh M., Hanyu A., Ebina M., Nukiwa T., Miyazawa K., Imamura T., Miyazono K. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J. 22:2003;6458-6470
28. Kretschmer A., Moepert K., Dames S., Sternberger M., Kaufmann J., Klippel A. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Oncogene. 22:2003;6748-6763
29. Ellenrieder V., Zhang J.S., Kaczynski J., Urrutia R. Signalling disrupts mSin3a binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor. EMBO J. 21:2002;2451-2460
30. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 62:2002;65-74
31. Geng M.M., Ellenrieder V., Wallrapp C., Muller-Pillasch F., Sommer G., Adler G., Gress T.M. Use of representational difference analysis to study the effect of TGFB on the expression profile of a pancreatic cancer cell line. Genes Chromosomes Cancer. 26:1999;70-79
32. Kleeff J., Ishiwata T., Maruyama H., Friess H., Truong P., Buchler M.W., Falb D., Korc M. The TGF-beta signalling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene. 18:1999;5363-5372
33. Moore P.S., Sipos B., Orlandini S., Sorio C., Real F.X., Lemoine N.R., Gress T., Bassi C., Kloppel G., Kalthoff H., Ungefroren H., Lohr M., Scarpa A. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 439:2001;798-802
34. Afrakhte M., Moren A., Jossan S., Itoh S., Sampath K., Westermark B., Heldin C.H., Heldin N.E., ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun. 19:1998;505-511
35. He W., Cao T., Smith D.A., Myers T.E., Wang X.J. Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene. 20:2001;471-483
36. Goggins M., Shekher M., Turnacioglu K., Yeo C.J., Hruban R.H., Kern S.E. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 58:1998;5329-5332
37. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353
38. Schutte M., Hruban R.H., Hedrick L., Cho K.R., Nadasdy G.M., Weinstein C.L., Bova G.S., Isaacs W.B., Cairns P., Nawroz H., Sidransky D., Casero R.A. Jr, Meltzer P.S., Hahn S.A., Kern S.E. DPC4 in various tumor types. Cancer Res. 56:1996;2527-2530
39. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L.C., Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana J.L., Attisano L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinomas. Cell. 86:1996;543-552
40. Kretzschmar M., Doody J., Timokhina I., Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13:1999;804-816
41. Calonge M.J., Massague J. Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. J Biol Chem. 274:1999;33637-33643
42. Zhao J., Buick R.N. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Cancer Res. 55:1995;6181-6188
43. Lemoine N.R., Jain S., Hughes C.M., Staddon S.L., Maillet B., Hall P.A., Kloppel G. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology. 102:1992;230-236
44. Malats N., Porta M., Corominas J.M., Pinol J.L., Rifa J., Real F.X. Ki-ras mutations in exocrine pancreatic cancer association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators. Int J Cancer. 70:1997;661-667
45. Wong C., Rougier-Chapman E.M., Frederick J.P., Datto M.B., Liberati N.T., Li J.M., Wang X.F. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol. 19:1999;1821-1830
46. Lee K.S., Hong S.H., Bae S.C. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene. 21:2002;7156-7163